StockData
Helus Pharma Inc. logo

Helus Pharma Inc. (HELP) stock

HELPNasdaqPharmaceutical PreparationsFiscal year ends March 31
Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 40-F on Jun 29, 2026Score 0/30
$8.86−0.53 (-5.64%)

Close on Nov 12, 2026Market cap $457.46MP/E –Yield –

Helus Pharma operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

For fiscal 2025 it was -C$101.30M. The highest annual figure on record is -C$19.03M in fiscal 2021.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Mar 31, 2025-C$101.30M–
FY2024Mar 31, 2024-C$68.91M–
FY2023Mar 31, 2023-C$47.43M–
FY2022Mar 31, 2022-C$45.21M–
FY2021Mar 31, 2021-C$19.03M–

More Helus Pharma figures

See a number that looks wrong?